News Daily News Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients L.A. McKeown September 12, 2012
News Daily News PROTECT II Published: Study of Percutaneous LVAD vs. IABP Sends Mixed Signals Caitlin E. Cox September 10, 2012
News Industry News Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival August 30, 2012
News Conference News ESC 2012 STEMI Patient Population Evolves Over 15 Years Yael L. Maxwell August 27, 2012
News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012
News Conference News ESC 2012 Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD August 26, 2012
News Daily News Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS L.A. McKeown August 20, 2012
News Daily News Study Suggests Shortening Delay to Noncardiac Surgery After PCI Yael L. Maxwell August 17, 2012
News Daily News Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease Caitlin E. Cox August 16, 2012
News Daily News PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients L.A. McKeown August 15, 2012
News Daily News Hurdles Remain in Shortening Reperfusion Times for Transferred STEMI Patients Yael L. Maxwell August 15, 2012
News Daily News Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib L.A. McKeown August 09, 2012
News Daily News Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA L.A. McKeown August 09, 2012
News Daily News JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations Yael L. Maxwell August 09, 2012
News Daily News Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina Jason Kahn July 17, 2012
News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012
News Industry News Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows June 26, 2012